A Study of RTP-026 to Assess Safety, Tolerability and Efficacy in Patients With ST-Elevation Myocardial Infarction (STEMI)

Clinical trial NCT06465303 · RECRUITING

Trial details

NCT number: NCT06465303
Sponsor: ResoTher Pharma
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

ST Elevation Myocardial Infarction

Start date: 2024-07-16
Primary completion: 2025-12-21
Enrollment: 96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.